ISTA - Kei - I took a quick look and ISTA looks like a good investment as well as a decent trade on a binary event.
They recently posted a profitable quarter, they have four marketed products as well as a deep pipeline and recently secured an SPA for their Phase 3 trial of REMURA in dry eye disease.
See below:
ISTA Pharmaceuticals Reports Second Quarter 2010 Financial Results - Revenues Increased 46% Over Prior-Year Quarter to $35.1 Million - - ISTA Reaffirms 2010 Guidance, Aims for First Year of Profitability - - (excluding warrant charges) -
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.